Evidence from epidemiologic studies indicates that maternal obesity is a risk factor for neurodevelopmental disorders in children. A case-control study of autism spectrum disorders (ASDs) in California recently demonstrated that mothers who were obese before pregnancy had a 67% increase in risk of having children with ASDs. 1 Other studies have found that children of obese mothers have an increased occurrence of attention-deficit/hyperactivity disorder symptoms, 2 an increased risk of intellectual disability (IQ ,70), 3 lower mean scores on cognitive testing, 4 and a higher risk of schizophrenia later in life. 5 The association between maternal prepregnancy obesity and child cognition is not consistent across studies; some studies have found no such associations. 6 It is commonly assumed that the harm to the child is caused by unfavorable effects of maternal obesity on the intrauterine environment. However, previous studies have not been designed to differentiate between intrauterine exposures and genetic associations, because the father' s BMI has not been taken into account. This study sought to expand on previous knowledge by investigating the relative risks of ASDs in children associated with both maternal and paternal BMI, using data from a longitudinal, prospective pregnancy cohort, the Norwegian Mother and Child Cohort Study (MoBa). 7 
METHODS

Study Population and Outcome Information
The MoBa cohort is nationwide and includes 109 000 children born from 1999 to 2009. Mothers were recruited at ultrasound examinations at approximately week 18 of pregnancy, and 38.5% of the invited women consented to participation. Cases of ASDs (autistic disorder, Asperger disorder, and pervasive developmental disorder not otherwise specified [PDD-NOS]) have been identified by a substudy of autism, the Autism Birth Cohort (ABC) Study. 8 The modes of case identification were (1) questionnaire screening of mothers at offspring ages 3, 5, and 7 years; (2) professional and parental referrals of children suspected of having ASD; and (3) linkage to the Norwegian Patient Register (NPR). 9 The NPR collects data on diagnoses from all hospitals and outpatient clinics in Norway, thereby capturing data for all children diagnosed with ASDs by Norwegian specialist health services. 9 The analyses in this study reflect data collected and processed by December 31, 2012 . The children eligible for analyses were MoBa participants recorded to be alive and living in Norway beyond 3 years of age.
When a child with ASD or potential ASD was detected through any of these mechanisms, he or she was invited to participate in a clinical assessment that included the research-standard instruments for diagnosis of ASDs, the Autism Diagnostic Interview-Revised, 10 and the Autism Diagnostic Observation Schedule, 11 which have shown high reliability and validity in making diagnoses of ASDs in children. Diagnostic conclusions were best-estimate clinical diagnoses derived from test and interview results and from information collected from parents and teachers. The diagnoses were based on Diagnostic and Statistical Manual of Mental Disorders (DSM), Fourth Edition, Text Revision criteria, and the case definition includes codes 299.00 (autistic disorder), 299.80 (Asperger disorder), and 299.80 (PDD-NOS). 12 The NPR contains International Classification of Diseases, 10th Revision codes determined by Norwegian specialist health services, and the ASD case definition of this study includes codes F84.0 (childhood autism), F84.1 (atypical autism), F84.5 (Asperger syndrome), F84.8 (other pervasive developmental disorder), and F84.9 (pervasive developmental disorder, unspecified). In this article, we have used the terms "autistic disorder" for code F84.0 and "PDD-NOS" for codes F84.1, F84.8, and F84.9.
Participation in MoBa and the ABC Study is based on written informed consent from the mother. Both studies are approved by the regional committee for medical and health research ethics for Southeastern Norway.
Exposure Information
Maternal and paternal height and weight were recorded in a questionnaire completed by the mothers during week 18 of pregnancy. Maternal prepregnancy BMI and paternal BMI were calculated by dividing weight in kilograms by height in meters squared. Weight categories were defined according to World Health Organization additive models with a logit-link were fitted in R (mgcv package) using a cubic regression spline with 2 degrees of freedom. The parental BMIs were included as continuous terms. The odds ratio scale in each model was centered around and set to 1 on the mean population odds of a given ASD estimated from the specific model. ORs with 95% CIs were plotted against maternal/ paternal BMI.
RESULTS
A total of 106 958 children were eligible for analyses. Children born in 2009 (n = 3354) were excluded because of low numbers of identified ASD cases. Of the remaining 103 604 children, 10 695 had missing data on maternal and paternal height and weight. The distribution of covariates among these study subjects indicated that mean BMI was likely to be somewhat higher for those with missing data and that the data may be missing not at random. Because of this, we chose to exclude them rather than impute the missing BMI values. The final study sample included 92 909 children. At the end of follow-up, the age range was 4.0 through 13. 14 were (-2.9 to 2.9) cm for height and (-5.6 to 5.0) kg for weight. The k statistic for paternal obesity was 0.91.
The distribution of maternal and paternal obesity across the categories of potential confounders and mediators is shown in Table 2 . In both mothers and fathers, obesity was associated with lower levels of education and higher levels of smoking. Obese mothers were less likely to be first-time mothers and to have used periconceptional folic acid supplements, and more likely to have used hormone treatment to become pregnant. They also had a higher risk of type 2 diabetes, gestational diabetes, and preeclampsia, and their children had a higher risk of premature birth (gestational age ,37 weeks) and of having a birth weight $4500 g. Table 3 shows the results of the logistic regression analyses. These analyses generated different results for the individual ASD subtypes, and we have reported subtype-specific ORs as well as ORs for the entire autism spectrum. The analyses for autistic disorder and PDD-NOS included the whole study sample. The analyses for Asperger disorder and ASD as a whole included only children born in 1999 to 2005 (aged $7 years at the end of follow-up) because few cases of Asperger disorder had been identified among the younger children.
Autistic disorder had been diagnosed in 0.27% (24 of 8936) of children of obese There was no evidence of interaction between maternal and paternal obesity based on the likelihood ratio test of nested models (P = .58).
Neither maternal nor paternal BMI was associated with the risk of PDD-NOS in children ( Table 3 ). The association between maternal obesity and Asperger disorder appeared to be similar to that for autistic disorder (Table 3) , although the 95% CIs included 1 in all models. The association with paternal obesity was stronger and more robust: Asperger disorder had been diagnosed in 0.38% (18 of 4761) of children of obese fathers, compared with 0.18% (42 of 22 736) of normal-weight fathers, generating an adjusted OR of 2.01 (95% CI: 1.13-3.57) (Model B). Again, no interaction was evident between maternal and paternal obesity (P = .47).
The increase in risk associated with paternal obesity was still present when all ASD subtypes were analyzed as a single outcome (Table 3) , with an adjusted OR of 1.53 (95% CI: 1.07-2.17) of ASDs for children of obese fathers (Model B).
Potential dose-response effects of maternal and paternal BMI were explored in generalized additive models. The results are displayed in Figs 1, 2 , 3, and
FIGURE 1
Risk of autistic disorder according to maternal and paternal BMIs: generalized additive models. In the adjusted models, maternal and paternal BMIs were adjusted for each other and for parental education levels, child' s year of birth, and maternal parity.
4. For maternal BMI, the unadjusted models suggested a continuous increase in odds of autistic disorder and Asperger disorder by increasing BMI for BMI values .25, but this was attenuated by adjustment for covariates and paternal BMI. In contrast, there was an exponential increase in odds of autistic disorder with increasing paternal BMI through the whole range of BMI values, and this association was largely unaffected by adjustment for covariates and maternal BMI. The 95% CI was .1 for paternal BMI .30. There was also a continuous increase in risk of Asperger disorder by paternal BMI for BMI values .27, but the 95% CI included 1 throughout.
DISCUSSION
The main finding of this study was that children of obese fathers have an increased risk of developing autistic disorder and Asperger disorder. The analyses showed that a dose-response relation may be present, so that the risks of these 2 disorders increase by increasing paternal BMI. The associations were largely unaffected by adjustment for sociodemographic and lifestyle characteristics. Our finding came as a surprise because we had expected maternal obesity to be the most prominent risk factor. Maternal obesity was also associated with an increased risk of both autistic disorder and Asperger disorder in unadjusted analyses, but the increase was substantially attenuated by adjustment for paternal BMI.
The previously mentioned study from California found an OR of 1.67 (95% CI: 1.10-2.56) of ASDs for children of obese mothers. 1 We did not replicate this association for ASDs as a whole, but it is worth noting that we obtained OR estimates of a similar magnitude in the models for autistic disorder and Asperger disorder that only included maternal BMI. The attenuation caused by adjustment for paternal BMI in our analyses indicates that paternal BMI is an important confounder of the
FIGURE 2
Risk of PDD-NOS according to maternal and paternal BMIs: generalized additive models. In the adjusted models, maternal BMI and paternal BMIs were adjusted for each other and for parental education levels, child' s year of birth, and maternal parity.
association between maternal obesity and ASD risk in children. 20 This mode of risk transmission would also be compatible with the gender-specific genetic effects on BMI that have been demonstrated in twin studies. 21 Another possible mode of risk transmission is through epigenetic alterations caused by paternal obesity, for example, obesity-induced changes in DNA methylation or other mechanisms regulating gene expression. It is still largely unknown whether the epigenetic features of human germline cells are affected by obesity or other environmental exposures, 22 but it has been demonstrated that children of obese fathers display changes in the expression of genes regulating early growth. 23 Animal studies have also shown that paternal obesity has transgenerational effects and
FIGURE 3
Risk of Asperger disorder according to maternal and paternal BMIs: generalized additive models. In the adjusted models, maternal and paternal BMIs were adjusted for each other and for parental education levels, child' s year of birth, and maternal parity.
that those effects are likely to be mediated through epigenetic mechanisms. 24 We did not find any associations for the PDD-NOS subtype of ASD. PDD-NOS does not have any specific diagnostic criteria, but it is used as a subthreshold category for children who have some autistic features but not sufficient to meet the specific diagnostic criteria for autistic disorder or Asperger disorder. The PDD-NOS subtype encompasses a heterogeneous group of children in our study sample, ranging from children with congenital syndromes and profound mental retardation to high-functioning children with milder symptoms of autism. The fact that the associations with paternal obesity were observed only for autistic disorder and Asperger' s disorder indicates that they cannot entirely be attributed to residual confounding; if residual confounding was substantial, we would have expected to find associations across all ASD subtypes.
The main limitation of the study was that the self-reported height and weight measures for the parents have not been validated through objective measurements. However, data from 2 contemporary British and Dutch pregnancy cohorts indicate that pregnant women generally report their own height and weight accurately; correlations between self-reported and objectively measured BMIs in pregnant women were 0.97 and 0.96, respectively. 6 No similar validation data are available for fathers, but the high level of agreement between maternal and paternal report in our study sample supports the accuracy of the self-reported paternal measures.
The other main limitation was the reliance on subtype diagnoses of ASDs. ASD subtype diagnoses have not been found to have high reliability across assessment sites in the United States, 25 and the division into subtypes has been removed altogether from the just-released DSM-5 classification system. 26 Still, our analyses for ASD as a whole showed that the association for paternal obesity, which was the most prominent finding, persisted even when subtype diagnoses were ignored.
FIGURE 4
Risk of ASD according to maternal and paternal BMIs: generalized additive models. In the adjusted models, maternal and paternal BMIs were adjusted for each other and for parental education levels, child' s year of birth, and maternal parity.
There is an underrepresentation of socially disadvantaged parents in the MoBa cohort, and this may limit the generalizability of our findings. 27 We have evaluated the potential effects of selection bias in MoBa by analyzing the associations between ASDs and 7 selected exposures in parallel in MoBa and the general Norwegian population. 28 The differences were small for all the associations investigated, indicating that exposure-disease associations for ASDs are not substantially affected by selection bias. 28 This is in line with analyses of other exposure-disease associations from MoBa 27 and from contemporary Danish 29, 30 and British 31 pregnancy cohorts.
The strengths of the study were the prospective cohort design, large sample size, and the combination of screening, referrals, and registry linkage for detection of ASD cases. Exposure and covariate data were collected in midpregnancy, which minimized the risk of recall bias. Our ability to link the cohort to the nationwide patient registry ensured that all diagnosed cases of ASDs in the study sample were detected, regardless of whether parents had responded to the cohort questionnaires.
CONCLUSIONS
Our study is the first to implicate paternal overweight and obesity as independent risk factors for ASDs in children. If the associations were to represent a causal relation, it would have large public health implications, given the increasing prevalence of obesity worldwide. The potential effects should be further investigated through attempts at replication of our analyses, and, if these are positive, through genetic and epigenetic studies. It should also be explored whether paternal overweight and obesity are associated with an increased risk of other neurodevelopmental disorders in children.
